This topic contains a solution. Click here to go to the answer

Author Question: When assessing the fixed-payment coverage ratio, ________. A) the lower its value the more risky ... (Read 21 times)

silviawilliams41

  • Hero Member
  • *****
  • Posts: 560
When assessing the fixed-payment coverage ratio, ________.
 
  A) the lower its value the more risky is the firm
  B) the lower its value, the higher is the firm's financial leverage
  C) preferred stock dividend payments can be disregarded
  D) the higher its value, lesser is its reliability to pay up the debts

Question 2

The cost of retained earnings is always lower than the cost of a new issue of common stock due to the absence of flotation costs when financing projects with retained earnings.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ntsoane kedibone

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

A

Answer to Question 2

TRUE




silviawilliams41

  • Member
  • Posts: 560
Reply 2 on: Jul 11, 2018
Wow, this really help


ktidd

  • Member
  • Posts: 319
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library